Journal Pre-proof
In a 15 mL round-bottomed flask, a mixture of aromatic aldehyde (1 mmol), molononitrile (1.1 mmol), the requested C–H activated
acidic compound (1 mmol), and [(DABCO)2C3H5OH]·2Cl (10 mg, 2.8 mol%) in water (3 mL) stirred magnetically under reflux
conditions. The progress of the reaction was monitored by TLC (n-hexane-EtOAc (8:2)). After completion of the reaction, the
mixture was diluted with water (3 mL) and the solid product was decanted. Recrystallization from ethanol afforded the pure product
in high yields.
2.6. General procedure for the synthesis of polyhydroquinoline derivatives
In a 10 mL round-bottomed flask a mixture of aromatic aldehyde (1 mmol), dimedone or 1,3-cyclohexanedione (1 mmol), ethyl
acetoacetate or methyl acetoacetate (1 mmol), ammonium acetate (2 mmol) and [(DABCO)2C3H5OH]·2Cl (30 mg, 8.5 mol%) was
stirred and heated in an oil-bath at 120 oC for an appropriate period of time. After completion of the reaction (Monitored by TLC),
water was added to separate the catalyst and the crude product was separated and recrystallized from EtOH to afford the requested
product.
2.7. Spectroscopic data of the selected previously introduced and new compounds
1
2-amino-4-(2-chlorophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (Table 3, entry 3, 2c): H NMR
(500 MHz, DMSO-d6): 훿 (ppm) 0.98 (s, 3H), 1.07 (s, 3H), 2.09 (d, J=8.0 Hz, 1H), 2.27 (d, J=8.0 Hz, 1H), 2.53(s, 2H), 4.70 (s, 1H),
7.03 (s, 2H), 7.16-7.22 (m, 2H), 7.26-7.29 (m, 1H), 7.36-7.38 (m, 1H); 13C NMR (125 MHz, DMSO-d6): 훿 (ppm) 196.0, 163.6,
159.1, 119.7, 112.2, 57.3, 50.4, 40.5, 39.4, 32.3, 28.8, 27.3, 142.0, 130.4, 129.9, 128.6. FT-IR (KBr, cm-1): 3469, 2962, 2196, 1600.
White solid, m.p.= 213-215 °C.
Ethyl 4-(4-chlorophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (Table 4, entry 2, 5b): 1H NMR (400
MHz, CDCl3): δ (ppm) 0.948 (s, 3H, CH3), 1.086 (s, 3H, CH3), 1.219 (t, J=7.2 Hz, 3H, CH3), 2.143-2.345 (m, 4H, CH2), 2.386 (s,
3H), 4.08 (q, J = 7.2 Hz, 2H), 5.047 (s, 1H, CH), 6.5 (br, 1H, NH), 7.18 (d, J= 8.3 Hz, 2H, ArH), 7.28 (d, J = 8.2 Hz, 2H, ArH). FT-
IR (KBr, cm-1): 3284, 3212, 3075, 2948, 1698, 1611, 1481, 1377, 1227, 1079, 828. White solid, m.p.= 236-238 °C.
1
Ethyl 4-(4-methoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (Table 4, entry 6, 5f): H NMR
(400 MHz, CDCl3): δ (ppm) 0.952 (s, 3H, CH3), 1.073 (s, 3H, CH3), 1.236 (t, 3H, J=7.4 Hz, CH3), 2.178-2.269 (m, 4H), 2.362 (s,
3H), 3.744 (s, 3H), 4.085 (q, 2H, J=7.4 Hz, OCH2), 5.17 (s, 1H, CH), 6.742-6.764 (d, 2H, J=8.8 Hz, ArH), 7.23 (d, 2H, J=8.8 Hz,
ArH), 7.292 (s, 1H, NH). FT-IR (KBr, cm−1): 3278, 3201, 3077, 2959, 1702, 1604, 1498, 1379, 1272, 1223, 1108, 1071, 1030, 841,
760. Pale yellow solid, m.p = 255-257 °C.
1
Ethyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (Table 4, entry 11, 5k): H NMR (400
MHz, CDCl3): δ (ppm) 0.920 (s, 3H, CH3), 1.092 (s, 3H, CH3), 1.199 (t, 3H, J=7.3 Hz, CH3), 2.15 (dd, 2H, CH2), 2.26 (dd, 2H,
4